Dr. Nilasha Ghosh is an Assistant Attending Rheumatologist at HSS, as well as an Assistant Professor of Medicine at Weill Cornell Medical College. She is board certified in Internal Medicine and Rheumatology. She specializes in the care of various rheumatic conditions and also works closely with the physicians at Weill Cornell and Memorial Sloan Kettering to take care of patients with complications of their rheumatic diseases.
Dr. Ghosh, a former fellow at HSS, has spent her career taking care of patients with rheumatologic disease and focuses on a comprehensive approach to patient care with both pharmacologic and non-pharmacologic therapies. Being a former varsity athlete at Stanford University, she understands the importance of physical function to maintaining one’s health. She also received her Masters in clinical research from Weill Cornell Medical College. Her research interests include inflammatory arthritis, rheumatic complications from checkpoint inhibitors and medical education.
Autoimmune complications of cancer therapies
Interstitial lung disease
Systemic lupus erythematosus
Trigger finger injection
Please call our office if you have questions regarding your insurance coverage. If you have out of network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Assistant Attending Physician, Hospital for Special Surgery
Assistant Professor of Medicine, Weill Cornell Medical College
Assistant Attending Physician, Memorial Sloan Kettering Cancer Center
American College of Rheumatology Distinguished Fellow Award, 2021
University of California, Irvine, 2015
Northwestern Memorial Hospital, 2016
Northwestern Memorial Hospital, 2018
Hospital for Special Surgery, 2021
Ghosh N, Bass AR. Rheumatic Complications of Immune Checkpoint Inhibitors. Med Clin North Am. 2021
Mar;105(2):227-245. doi: 10.1016/j.mcna.2020.09.009. PMID: 33589099.
Ghosh, N., Chan, K. K., Jivanelli, B., & Bass, A. R. (2021). Autoantibodies in Patients With Immune-Related Adverse Events From Checkpoint Inhibitors: A Systematic Literature Review. Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases.
Ghosh N, Tirpack A, Chan KK, Bass AR. Impact of COVID-19 on patients with rheumatic complications of cancer immunotherapy: results of a registry survey. J Immunother Cancer. 2020 Oct;8(2):e001550. doi: 10.1136/jitc-2020- 001550. PMID: 33067320; PMCID: PMC7569707.
Chan KK, Tirpack A, Vitone G, Benson C, Nguyen J, Ghosh N, Jannat-Khah D, Bykerk V, Bass AR. Higher Checkpoint Inhibitor Arthritis Disease Activity may be Associated With Cancer Progression: Results From an Observational Registry. ACR Open Rheumatol. 2020 Oct;2(10):595-604. doi: 10.1002/acr2.11181. Epub 2020 Oct 3. PMID: 33010198; PMCID: PMC7571396.
Ghosh N, Tiongson MD, Stewart C, Chan KK, Jivanelli B, Cappelli L, Bass AR. Checkpoint Inhibitor-Associated Arthritis: A Systematic Review of Case Reports and Case Series. J Clin Rheumatol. 2020 Apr 25:10.1097/RHU.0000000000001370. doi: 10.1097/RHU.0000000000001370. Epub ahead of print. PMID: 32345841; PMCID: PMC7606361.
Mirza SZ, Cheah JTL, Ghosh N, Robson JC, Hill CL, Singh J, Mackie SL, Navarro-Millán I, Simon LS, Goodman SM. The Patients' Perspective of Important Glucocorticoid Effects: A Nominal Group Study Among Patients With Systemic Lupus Erythematosus and Myositis. J Clin Rheumatol. 2020 Jan 24:10.1097/RHU.0000000000001313. doi: 10.1097/RHU.0000000000001313. Epub ahead of print. PMID: 31985721; PMCID: PMC7377954.
Ghosh N, Bass AR. Checkpoint Inhibitor-Associated Autoimmunity: What a Rheumatologist Needs to Know. J Clin Rheumatol. 2019 Nov 15. doi: 10.1097/RHU.0000000000001209. Epub ahead of print. PMID: 31743272.
Gard LA, Peterson J, Miller C, Ghosh N, Youmans Q, Didwania A, Persell SD, Jean-Jacques M, Ravenna P, O'Brien MJ, Sanghavi Goel M. Social Determinants of Health Training in U.S. Primary Care Residency Programs: A Scoping Review.Acad Med. 2019 Jan;94(1):135-143. doi: 10.1097/ACM.0000000000002491. PubMed PMID: 30334837.
Ghosh N, Ruderman EM. Nonradiographic axial spondyloarthritis: clinical and therapeutic relevance. Arthritis Res Ther. 2017 Dec 22;19(1):286. doi: 10.1186/s13075-017-1493-8. Review. PubMed PMID: 29273055; PubMed Central PMCID: PMC5741895.
Ghosh N, Kruse D, Subeh M, Lahham S, Fox JC. Comparing Point-of-care-ultrasound (POCUS) to MRI for the Diagnosis of Medial Knee Injuries. J Med Ultrasound. 2017 Jul-Sep;25(3):167-172. doi: 10.1016/j.jmu.2017.06.004. Epub 2017 Aug 17. PubMed PMID: 30065483; PubMed Central PMCID: PMC6029305.
González-Fernández M, Ghosh N, Ellison T, McLeod JC, Pelletier CA, Williams K. Moving beyond the limitations of the visual analog scale for measuring pain: novel use of the general labeled magnitude scale in a clinical setting. Am J Phys Med Rehabil. 2014 Jan;93(1):75-81. doi: 10.1097/PHM.0b013e31829e76f7. PubMed PMID: 23900013.
One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
As of August 02, 2021, Dr. Ghosh reported no relationships with healthcare industry.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.